Fitch joined a 37-state coalition requesting that the FDA to take action against bad actors who are endangering consumers with counterfeit weight loss drugs.

Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes.” ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Mississippi Attorney General Lynn Fitch joined a bipartisan 37-state coalition requesting that the Food and Drug ...

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

While some orthopedic and spine surgeons are divided on how medications used for weight loss, including Ozempic and Wegovy, will shape the field, it is undeniable that the drugs are playing an ...

Attorney General Kwame Raoul is leading a bipartisan coalition of 37 states and territories urging the Food and Drug ...

A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...

The weakness was also weighing on shares of some of Walmart's rivals, as Costco Wholesale Corp.'s stock (COST) fell 2.2% and Target Corp. shares (TGT) shed 1.1%, to underperform the S&P 500 index's ...

In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...